Insider Shareholders with Direct Ownership of Clovis Oncology, Inc. (CLVS)
This section provides a comprehensive overview of the insiders with direct ownership of Clovis Oncology, Inc. (CLVS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Clovis Oncology, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gillian C Ivers Read
Officer |
191,208 | 110,327 | 293,612 $26,425 | 38 |
Nov 02, 2022
Reduced 0.68%
|
|
Lindsey Rolfe
Officer |
141,047 | 78,353 | 113,691 $10,232 | 38 |
Nov 02, 2022
Reduced 2.03%
|
|
Daniel W Muehl
Officer |
136,176 | 64,420 | 104,830 $9,434 | 34 |
Nov 02, 2022
Reduced 1.93%
|
|
Paul Edward Gross
Officer |
136,176 | 64,876 | 98,330 $8,849 | 35 |
Nov 02, 2022
Reduced 2.13%
|
|
Brian G Atwood
Director |
6,896 | 0 | 32,758 $2,948 | 1 |
Nov 09, 2020
Added 17.39%
|
|
Thomas C. Harding
Officer |
52,017 | 35,740 | 19,487 $1,753 | 33 |
Nov 02, 2022
Reduced 4.48%
|